Specifically, the IM subtype exhibited a robust immune infiltration, along with a FI spatial distribution pattern, an increased density of CTLA-4+ and PD-1+ TILs, and high PD-L1 expression by tumor cells, indicative of “immune-hot” tumors. The gene discussed is CTLA4; the disease is neoplasm.